• 1
    Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894921.
  • 2
    Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2003;2:104113.
  • 3
    Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007;61:13611369.
  • 4
    Makris N, Biederman J, Monuteaux MC, Seidman LJ. Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder. Dev Neurosci 2009;31:3649.
  • 5
    Agarwal N, Port JD, Bazzocchi M, Renshaw PF. Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology 2010;255:2341.
  • 6
    Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006;39(Suppl 1):S10S14.
  • 7
    MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 2003;53:184187.
  • 8
    Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: Preliminary findings. J Neuropsychiatry Clin Neurosci 2004;16:6369.
  • 9
    Ferreira PE, Palmini A, Bau CH, et al. Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: A (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions. J Neural Transm 2009;116:623629.
  • 10
    Perlov E, Tebarzt van Elst L, Buechert M, et al. H1-MR-spectroscopy of cerebellum in adult attention deficit/hyperactivity disorder. J Psychiatr Res 2010;44:938943.
  • 11
    Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:1117.
  • 12
    Moore CM, Frazier JA, Glod CA, et al. Glutamine and glutamate levels in children and adolescents with bipolar disorder: A 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am Acad Child Adolesc Psychiatry 2007;46:524534.
  • 13
    Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: A preliminary case series. J Child Adolesc Psychopharmacol 2002;12:331336.
  • 14
    Carrey N, MacMaster FP, Fogel J, et al. Metabolite changes resulting from treatment in children with ADHD: A 1H-MRS study. Clin Neuropharmacol 2003;26:218221.
  • 15
    Kronenberg G, Ende G, Alm B, Deuschle M, Heuser I, Colla M. Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD. Eur Arch Psychiatry Clin Neurosci 2008;258:446450.
  • 16
    Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260264.
  • 17
    Moore CM, Biederman J, Wozniak J, et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: A proton magnetic resonance spectroscopy study. Am J Psychiatry 2006;163:316318.
  • 18
    Perlov E, Philipsen A, Matthies S, et al. Spectroscopic findings in attention-deficit/hyperactivity disorder: Review and meta-analysis. World J Biol Psychiatry 2009;10(4 Pt 2):355365.
  • 19
    Sun L, Jin Z, Zang YF, et al. Differences between attention-deficit disorder with and without hyperactivity: A (1)H-magnetic resonance spectroscopy study. Brain Dev 2005;27:340344.
  • 20
    Yang P, Wu MT, Dung SS, Ko CW. Short-TE proton magnetic resonance spectroscopy investigation in adolescents with attention-deficit hyperactivity disorder. Psychiatry Res 2010;181:199203.
  • 21
    Jensen JE, Licata SC, Ongur D, et al. Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla. NMR Biomed 2009;22:762769.
  • 22
    Russell VA. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder: The spontaneously hypertensive rat. Neurosci Biobehav Rev 2003;27:671682.
  • 23
    Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab 2006;26:865877.
  • 24
    Struzynska L. A glutamatergic component of lead toxicity in adult brain: The role of astrocytic glutamate transporters. Neurochem Int 2009;55:151156.
  • 25
    Zwingmann C, Leibfritz D, Hazell AS. Nmr spectroscopic analysis of regional brain energy metabolism in manganese neurotoxicity. Glia 2007;55:16101617.
  • 26
    Todd RD, Botteron KN. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry 2001;50:151158.
  • 27
    Meisingset TW, Risa O, Brenner M, Messing A, Sonnewald U. Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease. Glia 2010;58:12281234.
  • 28
    Russell VA, Oades RD, Tannock R, et al. Response variability in Attention-Deficit/Hyperactivity Disorder: A neuronal and glial energetics hypothesis. Behav Brain Funct 2006;2:30.
  • 29
    Sailasuta N, Abulseoud O, Hernandez M, Haghani P, Ross BD. Metabolic abnormalities in abstinent methamphetamine dependent subjects. Subst Abuse 2010;2010:920.